Pablo J Cagnoni is President, R&D of INCYTE CORP. Currently has a direct ownership of 221,170 shares of INCY, which is worth approximately $15.9 Million. The most recent transaction as insider was on Jul 15, 2024, when has been sold 749 shares (Common Stock) at a price of $64.25 per share, resulting in proceeds of $48,123. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 221K
0% 3M change
9.45% 12M change
Total Value Held $15.9 Million

PABLO J CAGNONI Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 15 2024
SELL
Payment of exercise price or tax liability
$48,123 $64.25 p/Share
749 Reduced 0.34%
221,170 Common Stock
Jul 15 2024
BUY
Grant, award, or other acquisition
-
19,851 Added 8.21%
221,919 Common Stock
Jul 14 2023
BUY
Grant, award, or other acquisition
-
9,668 Added 4.57%
202,068 Common Stock
Jun 05 2023
BUY
Grant, award, or other acquisition
-
179,613 Added 50.0%
179,613 Common Stock

Also insider at

CRSP
CRISPR Therapeutics AG Healthcare
RUBY
Rubius Therapeutics, Inc. Healthcare
FUSN
Fusion Pharmaceuticals Inc. Healthcare
PJC

Pablo J Cagnoni

President, R&D
Cambridge, MA

Track Institutional and Insider Activities on INCY

Follow INCYTE CORP and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells INCY shares.

Notify only if

Insider Trading

Get notified when an Incyte Corp insider buys or sells INCY shares.

Notify only if

News

Receive news related to INCYTE CORP

Track Activities on INCY